D. Walker

The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma

Roger E. Taylor, D. Hargrave, S. Bujkiewicz, 2010, Journal of Neuro-Oncology.

Left-handedness should not be overrated as a risk factor for postoperative speech impairment in children after posterior fossa tumour surgery: a prospective European multicentre study

P. Grillner, K. V. van Baarsen, G. von Oettingen, 2022, Child's Nervous System.

TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity

M. Pirmohamed, S. Bailey, P. Brock, 2017, Pharmacogenetics and genomics.

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood ( 16 years ) low grade glioma e A final report

K. Skullerud, T. Egeland, D. Machin, 2017 .

The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)

M. Gaze, G. Horan, F. Saran, 2015, Pediatric blood & cancer.

Does early glottic cancer recur early? A retrospective study of recurrence and mortality in 61 patients with T1 and T2 glottic cancers

M. Harries, P. Bowles, Alison Liu, 2019, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Left-handedness should not be overrated as a risk factor for postoperative speech impairment in children after posterior fossa tumour surgery: a prospective European multicentre study

P. Grillner, K. V. van Baarsen, G. von Oettingen, 2022, Child's Nervous System.

Comprehensive Treatment strategy for Low Grade Glioma in children and adolescents including a randomized chemotherapy trial and a radiotherapy trial

J. Grill, G. Perilongo, J. Helgestad, 2008 .

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

K. Skullerud, T. Egeland, D. Machin, 2017, European journal of cancer.